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Abstract
It is thought that changes in mitochondrial DNA are associated with many degenerative diseases, including Alzheimer’s and
diabetes. Much of the evidence, however, depends on correlating disease states with changing levels of heteroplasmy
within populations of mitochondrial genomes, rather than individual mitochondrial genomes. Thus these measurements are
likely to either overestimate the extent of heteroplasmy due to technical artifacts, or underestimate the actual level of
heteroplasmy because only the most abundant changes are observable. In contrast, Single Molecule (SM) LATE-PCR analysis
achieves efficient amplification of single-stranded amplicons from single target molecules. The product molecules, in turn,
can be accurately sequenced using a convenient Dilute-‘N’-Go protocol, as shown here. Using these novel technologies we
have rigorously analyzed levels of mitochondrial genome heteroplasmy found in single hair shafts of healthy adult
individuals. Two of the single molecule sequences (7% of the samples) were found to contain mutations. Most of the
mtDNA sequence changes, however, were due to the presence of laboratory contaminants. Amplification and sequencing
errors did not result in mis-identification of mutations. We conclude that SM-LATE-PCR in combination with Dilute-‘N’-Go
Sequencing are convenient technologies for detecting infrequent mutations in mitochondrial genomes, provided great care
is taken to control and document contamination. We plan to use these technologies in the future to look for age, drug, and
disease related mitochondrial genome changes in model systems and clinical samples.
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Introduction
Mitochondria are the primary energy source of most eukaryotic
cells. Each mitochondrion possesses multiple copies of mitochon-
drial DNA (mtDNA). Human mitochondrial DNA is a 16 kb circle
that encodes for 13 genes electron transport chain proteins, 22
tRNAs, and two rRNAs. The mitochondrial genome also includes
a control region that contains the displacement loop (D-Loop),
within which DNA replication is initiated and gene transcription is
regulated. By convention one particular sequence, known as the
revised Cambridge Reference Sequence (rCRS), or the Anderson
sequence, serves as a reference sequence [1,2]. Variations from
this reference sequence at specific loci within the HVI and HVII
regions of the D-Loop define each person’s haplotype. Haplotypes
are used for forensic identification, and sequence changes with
respect to the haplotype can, at least theoretically, be used to
analyze mitochondrial diseases. Recently, mutations within the D-
Loop of mtDNA have been linked to specific diseases [3] including
diabetes [4], Alzheimer’s [5], and cancer [6]. There are multiple
mechanisms that could cause disease: a single point mutation that
is clonally expanded throughout the cell, or a build up of random
mutations (mutational load) that, having reached a threshold,
causes the onset of disease. Amplification of bulk samples will only
show the most abundant mutations which may or may not play a
significant role in disease development under mutational load
conditions. In order to observe the increase in mutations over time
it is necessary to amplify single mtDNA molecules. Studies using
such high resolution analysis are pivotal to understanding the
relationship of heteroplasmy to disease.
Published evidence for mtDNA heteroplasmy is controversial
for several technical reasons [7,8]. First, sequencing errors and
contamination can lead to overestimating the extent of hetero-
plasmy in a sample. Recently it has been shown by Yao et al. that
even single cell analysis of mtDNA is problematic due to
contamination within the laboratory space [9]. Even when
adequate controls for these artifacts are in place, most mtDNA
studies have involved PCR amplification starting with populations
of molecules followed by cloning or direct cloning of individual
mtDNA genomes prior to amplification and analysis [10–20]. The
use of populations of mtDNA detects only high frequency variants
within the population, while cloning makes it difficult to
distinguish between mutations (hereafter, true mutations) in the
starting genomes and those introduced during the construction
and selection of clones.
Both forms of cloning, PCR amplified or direct, have problems
analyzing single molecules. With direct cloning it is impossible to
distinguish between true mutations and mutations that occurred
during replication of the plasmid. With PCR amplification first,
any errors that take place during the PCR will be included in the
pool of cloned molecules, thereby making it impossible to
distinguish between true mutations and PCR errors.
Random mutation capture (RMC) [21,22] helps reduce the
number of molecules in a population and avoids cloning by using
restriction digestion. Wild type molecules at the enzyme-specific
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remaining molecules are then amplified. This technique has
several draw backs. The first is that RMC actually works best at a
population level and therefore suffers from not being able to
measure the breadth of mutations that may make up mutational
load at the single copy level. Second, most mutations of interest
occur outside the sequence cleaved by a single restriction enzyme.
This means that to survey widely distributed mutations multiple
restriction enzymes would have to be used in a manner that does
not interfere with subsequent PCR amplification of the resulting
fragments.
Direct amplification of single molecules followed by sequencing,
allows each strand of mtDNA to be individually analyzed, thereby
illuminating possible heteroplasmic differences between genomes
[23,24]. This approach makes it possible to detect low frequency
genetic changes at virtually any base pair. SM-LATE-PCR takes
advantage of the fact that LATE-PCR allows for efficient and
rapid generation of single stranded DNA [25,26]. Dilute-‘N’-Go
sequencing, in turn, allows for convenient dideoxy-sequencing of
the accumulated single-stranded DNA, as well as the template
strand from which it was generated [27].
Using LATE-PCR and Dilute-‘N’-Go sequencing, we have
shown that it is possible to detect mutations in the HVI region of
mtDNA at a single molecule level in hair samples of a 60 year old
male. Low numbers of true mutations were found based on a
conservative interpretation that any sequence that does not
maintain the same baseline sequence (rCRS or rCRS with
changes) as the original amplified bulk sample (this predominant
sequence is denoted as HV1‘) is likely to be an artifact due to
sample contamination. Indeed, in initial experiments high
numbers of contaminates were found, similar to recent studies
[9]. This observation led to a series of experiments designed to
establish: i) where the contamination was coming from, and ii) if
SM-LATE-PCR or Dilute-‘N’-Go sequencing were a source of
artifacts. Our data demonstrate that neither of these new
techniques introduces detectable changes in DNA sequences and
that the contamination observed came from within our laboratory.
These SM-LATE-PCR experiments establish both the technology
and the baselines needed to explore heteroplamy in the future
under rigorously controlled laboratory conditions.
Results
Analysis of Single mtDNA Molecules from Hair Shafts
This study was initiated using a 5 mm portion of a hair shaft
from a 60 year old male. The strand was first cleaned carefully and
was then lysed to avoid contamination (see methods). No hair root
was present, thereby ruling out the possibility of contamination
with nuclear genomic DNA, which is known to contain
pseudogenes for mitochondrial genes [28].
In order to achieve SM-LATE-PCR, we diluted the population
of mtDNA genomes in ten-fold steps (Figure 1a). The observed
DCt value at each step of the dilution series was about 3,
confirming that the LATE-PCR assay for amplification of HVI
was efficient [25]. Replicate samples diluted below 10 molecules
per assay have scattered CT values because the presence of a
genome per tube becomes stochastic (Figure 1b). The double-
stranded DNA melted at the temperature expected for our HVI
amplicon, 86.5uC (Figure 1c). The predominant HV1 sequence of
the undiluted population of genomes, hereafter designed HVI‘,
differed from the rCRS in four locations: 16136C, 16224C,
16311C, and 16320T (Tables 1 and 2).
SM-LATE-PCR was carried out by diluting the sample to
slightly less than the theoretical value of one molecule per well.
Accordingly, we recovered 28 positive signals out of 90 samples
when the sample was diluted to the single molecule level and
amplified by SM-LATE-PCR (Table 1). Two of the resulting 28
experimental sequences were clear contaminants: (M1) was the
Anderson Sequence and (M7) was a sequence with which we were
familiar from earlier experiments. M7 differed from the HVI‘
sequence at the following sites: 16111T, 16129A, 16223T,
16290T, 16319A, and 16362C (Table 2). Of the remaining 26
sequences 18 were identical to the HVI‘ sequence. Of the
remaining 8 sequences, 4 (M2–M5) contained a sequence of
16129A, 16136T, 16192T, 16223T, 16224T, 16297C, and
16320C rather than HVI‘ sequence (Table 2). The M2–M5
results, as well as the one NTC that amplified, were considered
contamination because they did not contain the same changes
relative to the rCRS as those that defined the HVI‘ sequence.
Sample M6a/M6b contained equal amounts of both the HVI‘
sequence and the sequence seen in samples M2–M5.
The final two samples in this set (M8 and M9) had the HVI‘
sequence but also had one (M8) or two (M9) additional base
changes. Even though the base changes in the M9 sequence have
not been previously observed, they fit the definition of true
mutations, that is changes that do not alter the baseline HVI‘
sequence. Although the sample size is very small, the rate of
change, two out of twenty-eight samples (7%), is consistent with
the average mutation rate reported by others [28]. Nevertheless,
the results obtained with the hair shaft sample were vexing because
they demonstrated that .8% (8 out of 90 total sample reactions) of
the amplified reactions were likely due to contaminants from
several sources, despite our efforts to avoid this problem. In
response we took a closer look at the possible sources of
contamination in these experiments.
Analysis of Single mtDNA No-Template Controls
In order to analyze the contamination problem in depth we
began by amplifying a large number of non-template controls to
determine whether our reagents or the laboratory environment
was the source of the problem. Accordingly, 288 control samples
were analyzed using the SM-LATE-PCR protocol. These controls
were run on two different PCR machines with fresh reagents each
time. Among the first 96 reactions, NTC-1, five wells generated a
signal. Two of these sequences had eight additional changes from
the canonical rCRS sequence (Table 1 and 3). The other three
positive reactions, samples 3, 4, and 5, had 6, 7, and 5 changes
respectively (Tables 1 and 3). None of the five NTC sequences
obtained in this experiment match the dominant HVI‘ sequence
of the hair sample.
Among the 96 NTC-2 reactions, three generated signals. Two
of these three had sequences observed in NTC-1. The third
sample had five changes (Table 3). Among the 96 NTC-3
reactions, 2 generated signals and both matched the NTC-1-1,
NTC-1-2, and NTC-2-2 sequences seen in the first two NTC
plates. Indeed, these sequences are identical to those observed in
earlier mitochondrial work in our laboratory on blood lympho-
cytes, even in the number and location of sequence changes.
The results from the NTC reactions indicate that some of the
contamination we observed came from amplicons released during
the earlier work on mitochondrial genomes. Having established
this pattern we can justifiably discount those sequences within the
set from hair shaft as cases of contamination rather than as true
mutations. This line of reasoning also supports our general
conclusion that samples that show several sequence changes from
the predominant sequence of that sample are likely to be
contaminants of unknown origin. None of the contaminants
picked up in these NTC experiments included the dominant
SM LATE-PCR of mtDNA Variation
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5636Figure 1. Amplification plots of (a) dilution series and (b) single molecules using blood lymphocyte mtDNA. (a) (*) equal NTC, (&)
10,000 copies, (¤) 1,000, (m) 100, and ($) 10 copies. (b) Single copy amplification has scattered Ct values. (&) equal single copy mtDNA, (*) equal
NTCs. (c) SYBR Green melts of HV1 samples. The predicted melt of the amplicon is 86.5. The samples do melt with a sharp peak at that temperature
showing that the sample has been amplified not only correctly but also cleanly.
doi:10.1371/journal.pone.0005636.g001
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indication that our current laboratory procedures are significant
improvements over our initial ones.
PCR and Sequencing Errors
Before drawing final conclusions from the above data, it was
important to demonstrate both the fidelity of the SM-LATE-PCR
amplification and the accuracy of Dilute-‘N’-Go dideoxy-sequenc-
ing by understanding the distribution of amplicon sequences in an
amplified single molecule sample. Both of these technologies were
validated by mitochondrial DNA from samples of hair shaft.
Accordingly, original hair shaft sample M2 LATE-PCR generated
amplicons were diluted to a single amplicon per microliter. LATE-
PCR amplification was repeated on 90 samples and analyzed for
sequence similarity to the original M2 amplicon sample.
Sample M2 was selected to determine if SM-LATE-PCR and
Dilute-‘N’-Go sequencing generated errors because it was one of
four amplified hair samples that had the same sequence. While the
M2–M5 samples were considered contaminants, it is difficult to
classify them as sequencing or amplification errors because the
same eight base changes were very unlikely to have arisen
independently in each of four reactions. Thirty-four of the diluted
M2 amplicons generated SM-LATE-PCR products. Twenty-four
of these samples had the same sequences, thereby defining
HVI‘M2. The other ten sequences each had individual changes
while retaining the HVI‘M2 sequence (Table 4). A priori, these
Table 1. List of results for hair shaft mitochondria experiments.
Experiment
(Number of Wells)
Total Number of Wells
That did not Amplify
Number of Samples
That Have the HV1‘ Sequence
Sample
Name
Number of Changes
from HV1‘
Hair Shaft (96) 68 18 M1 –
M2 8
M3 8
M4 8
M5 8
M6a 8
M6b –
M7 10
M8 1
M9 2
NTC 3
NTC 1 (96) 91 NA 1 8
28
36
46
55
NTC 2 (96) 93 NA 1 5
28
35
NTC 3 (96) 94 NA 1 8
28
Samples with an a or b following mean that they were two sequences in the same tube. (–) There were no mutations.
doi:10.1371/journal.pone.0005636.t001
Table 2. Table of sequences from the Hair amplifications.
Sample Sequence
Experimenter 16224C–16304C–16311C
Hair 16136C–16224C–16311C–16320T
M2, 3, 4, 5 16129A–16136T–16192T–16223T–16224T–16297C–16311T–16320C
M6 16129A/G–16136T/C–16192T/C–16223T/C–16224T/C–16297C/T–16311T/C–16320C/T
M7 16111T–16129A–16136T–16223T–16224T–16290T–16311T–16319A–16320C–16362C
M8 16187T
M9 16030T–16125T
Changes for the Hair and Experimenter are based off of the Anderson sequence. The changes for the hair mutations are based off of the Hair sequence, which makes up
the HV1‘ sequence. Heteroplasmy is indicated by a/.
doi:10.1371/journal.pone.0005636.t002
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Dilute-‘N’-Go sequencing or could be the result of errors during
the first round of SM-LATE-PCR amplification.
Errors due to Dilute-‘N’-Go sequencing of the Excess Primer
strand were ruled out by sequencing the complementary Limiting
Primer strand that is present in each sample. In every case the
Limiting Primer strand was fully complementary to its Excess
Primer strand (Figure 2). Therefore the sequence changes of the
ten HVI‘M2 were present in the amplicons themselves prior to
sequencing, were not due to sequencing errors, and would never
have been detected in bulk mtDNA amplifications (see below).
Each of the sequence changes observed in these 10 errant
HVI‘M2 samples were non-heteroplasmic at each altered position.
This means that they could not have arisen early in the process of
SM-LATE-PCR amplification for the following reason. When
amplification is initiated from a single molecule any base change
occurring during the first cycle of duplication results in a 50:50
mixture of sequences and any base change during the second cycle
of duplication results in a 75:25 mixture of sequences. Mixtures at
both of these levels are distinguishable from non-heteroplasmic
during sequencing. Amplification errors that arise during later
cycles do not leave a detectable trace by sequence analysis because
dideoxy-sequencing uses populations of template molecules.
We conclude that the 10 errant HVI‘M2 samples were present
together with the 24 unchanged HVI‘M2 molecule in the 34
template molecules recovered from sample M2. We further
conclude that these 10 errant HVI‘M2 molecules were produced
between the 3
rd and final round of double-stranded duplication in
the SM-LATE-PCR assay used to generate sample M2. As
discussed below the error rate of SM-LATE-PCR detected here is
consistent with the inherent error rate of symmetric PCR.
Discussion
Our long range goal is to accurately measure the levels of
heteroplasmy in mitochondrial genomes in relation to several
degenerative diseases. As a first step toward this goal, we analyzed
single molecules of mtDNA from a hair shaft in order to validate
SM-LATE-PCR. During this experiment we detected both true
mutations and mtDNA contamination. These findings led us to
carry out experiments aimed at revealing the source of
contamination and this analysis, in turn, allowed us to conclude
that the contamination problem largely arose from early
laboratory procedures. But, like Yao et al. [9], we also detected
contamination from unknown sources. Our final series of
experiments proved to be the most important for future research,
because it demonstrated that Dilute-‘N’-Go dideoxy-sequencing is
reliable and that the error rate inherent to SM-LATE-PCR is
consistent with that observed in symmetric PCR.
Single Molecule LATE-PCR Amplifications
We have chosen to define true mutations based on a conservative
interpretationofthedata.True mutationsaredefined asa changein
a DNA sequence at a location other than the defining HVI‘
sequence characteristic of that sample. Thus, two of twenty-eight
hair shaft sequences were scored as true mutations. This low rate of
true mutation, 7%, is similar to the mitochondrial HVI mutation
rate reported using other methods [29].
Our experiment also revealed the presence of contaminating
sequences in each sample set. But all of the contaminating
sequences could be traced to early experimental work in our
laboratory. While it is probably impossible to rid our laboratory of
these contaminants, we can justifiably discount their presence in
the future.
We conclude that SM-LATE-PCR is an extremely sensitive
method, and experience has taught us that amplification of non-
template controls prior to analysis of experimental samples is
critical in order to calibrate contaminants present in the laboratory
space and in reagents. Indeed, NTC amplifications may have to be
done repeatedly during experiments that are extended over a long
time. This requirement is particularly stringent when human
mitochondria are being analyzed.
Heteroplasmy Is Not Due to Sequencing Errors
Single molecules of mtDNA were amplified and sequenced bi-
directionally using Dilute-‘N’-Go dideoxy-sequencing. This
showed that sequencing errors do not occur using this novel
protocol. If such errors had taken place, the complementary
sequencing runs would have been non-complementary at the site
in question. When the Excess Primer Strand is used as the
sequencing template, there is a very low level of background signal
in the chromatogram. This background may be due to the
Limiting primer-strand, because some Excess Primer is still present
even after 1:20 dilution, and can still be extended during cycle
sequencing. But, this low background never results in a false base
call or a sequence ambiguity. No background is seen when the
Limiting Primer Strand is sequenced with the residual Excess
Table 3. Table of sequences from the NTC amplifications.
NTC-1-1, -2 16048A–16051G–16092C–16209C–16239T–16278T–16352C–
16353T
NTC-1-3 16126C–16158G–16163G–16186T–16189C–16294T
NTC-1-4 16167T–16192T–16223T–16298C–16311C–16325C–16327T
NTC-1-5 16126C–16293G–16294T–16296T–16304C
NTC-2-1 16129A–16192T–16223T–16297C–16303C
NTC-2-2 16048A–16051G–16092C–16209C–16239T–16278T–16352C–
16353T
NTC-2-3 16122G–16126C–16294T–16296T–16304C
NTC-3-1, -2 16048A–16051G–16092C–16209C–16239T–16278T–16352C–
16353T
NTC-1, NTC-2, and NTC-3 are the first, second, and third NTC amplification runs.
All changes are based off of the Anderson sequence.
doi:10.1371/journal.pone.0005636.t003
Table 4. Table of sequences from the re-amplification of the
M2 sample.
M2 16129A–16136T–16192T–16223T–16224T–16297C–16311T–16320C
M2-1 16048C
M2-2 16229A/T–16258G/A–16260T/C
M2-3 16100G
M2-4 16171G
M2-5 16175G
M2-6 16239T/C
M2-7 16137G–16180G
M2-8 16051G
M2-9 16023A
M2-10 16297T/C
All changes are based off of the M2 sequences. Heteroplasmy is indicated by a/.
doi:10.1371/journal.pone.0005636.t004
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Excess Primer Strand.
Heteroplasmy Is Not Due to Amplification Errors
Sequence differences among replicate SM-LATE-PCR assays are
not due to amplification errors for the following reasons. LATE-PCR
begins with symmetric PCR and then switches to repeated cycles of
linearamplificationinwhichtheLimitingPrimer-Strandservesasthe
template but does not itselfreplicate further. Thus, only amplification
errors that arise very early during the first phase of double-stranded
DNA amplification could measurably impact the composition of the
population of single-stranded amplicons that serve as templates for
post-amplification sequencing. In fact, when amplification begins
with a single molecule, an amplification that changes sequence would
have to occur during the very first or second cycle of amplification to
subsequently be detected via dideoxy-sequencing. Dideoxy-sequenc-
ing, including Dilute-‘N’-Go dideoxy-sequencing, generates and
linearly amplifies dideoxy-partial sequences from a population of
template molecules. For instance, if the initial template is comprised
of a 50:50 mixture of two sequences upon sequencing the
heteroplasmy is seen in the sequence results (M6 in Table 1).
However, the sensitivity of dideoxy-sequencing for detection of
heteroplasmy quickly falls off, i.e. 75:25 mixture of two sequences are
detectable,but88.5:12.5mixtureareusuallynot.Itfollowsfromthese
observations that pure sequence difference among different samples
generated by SM-LATE-PCR must have been present in the initial
population of molecules. This idea is further supported by earlier
work on single molecule PCR [23].
Symmetric PCR is Known to Generate Sequence Errors
Lin et al. calculated the rate of PCR-induced mutation to be
1.18610
24 errors/bp [30]. While that study used symmetric PCR
rather than LATE-PCR, the calculations were based on the error
insertion rate of a high-fidelity DNA polymerase, the same enzyme
as was used for amplifications discussed in this study. Thus, it can
be reasonably assumed that LATE-PCR will exhibit a similar rate
of error during the initial symmetric phase of amplification. It is
extremely unlikely that any of the sequence changes that we scored
as a ‘‘true’’ mutation was due to a PCR amplification error. Were
this to be the case, they would have to occur during either the first
or second round of amplification for the reasons outlined above.
Nevertheless SM-LATE-PCR Does Generate Sequence
Changes During Amplification
Although none of the heteroplasmy we observed after one
round of SM-LATE-PCR is explained as an artifact during early
amplification, this does not rule out the possibility that sequence
changes do occur at some point during SM-LATE-PCR. In order
Figure 2. Sequencing chromatograms of Sample M2-1. Both excess and limiting primers have been used to sequence the amplicon. What are
shown are the complementary sequences. Sequence ranges are given at the top of each section. Mutations have been indicated with black arrows.
The background seen when using the limiting strand is the product produced with what excess primer is left over after dilution.
doi:10.1371/journal.pone.0005636.g002
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generated by a first round of SM-LATE was diluted to the single
amplicon level. Replicates of these secondary single amplicons
were again subjected to SM-LATE-PCR and Dilute-‘N’-Go
sequencing. Our results show that, this time, 10 of 34 samples
were errant version of HVI‘M2 with 8 versions containing single
base changes. Using the above error rate from Lin et al., the
expected number of sequences with errors would be 6. We
conclude that these 10 errant HVI‘M2 samples reflect the presence
of at least 28.5% (10 out of 34) sequence variants generated by the
first SM-LATE-PCR amplification experiment on hair.
It follows from the above analysis that the first SM-LATE-PCR
amplification from an initial population of diluted mitochondrial
genomes provides an accurate picture of the sequence hetero-
plasmy within that population of genomes. However, the resulting
populations of amplicons generated by SM-LATE-PCR include
hidden sequence changes that arise during this first amplification.
It is important to emphasize, however, that none of the ‘‘true
mutations’’ described herein, nor any of the ‘‘contaminants’’
described herein reflects these hidden sequence changes because
all such conclusions were drawn from first round amplification of
single mitochondrial genomes.
Conclusions and Look to the Future. Applications for
mitochondrial research at the single genome level are numerous
and range from exploration of the mutation level present in single
cells and mitochondrion, to examination of the potential
mechanisms of mtDNA related disease. In-depth analysis requires
the use of a reliable method of single mtDNA amplification and
sequencing with the minimum chance of contamination. We have
shown here that SM-LATE-PCR and Dilute-‘N’-Go Sequencing is
such a method, that is not only useful but also does not generate
additional errors or suffer from contamination to any greater extent
than previously published reports [9,30]. Assays of heteroplasmy
among different tissues, between similar tissues at different stages of
life, or among maternally related individuals may potentially lead to
rigorously established rates of heteroplasmy that make it possible to
track disease relationships between groups of related and unrelated
people for the first time. LATE-PCR is a newly emerging technique
that has accounted for the problems inherent in conventional PCR.
We have proven here that LATE-PCR can reliably amplify single
molecules of mtDNA. This work also sets the bounds and controls
needed for future SM-LATE-PCR work. With strict controls in
place the combination of SM-LATE-PCR and Dilute-‘N’-Go
sequencing will likely emerge as a powerful new analytical
technique for single molecule analysis of mitochondrial DNA.
Materials and Methods
MtDNA extraction
Cell sampling techniques. Mitochondrial DNA from hair
shaft samples were extracted and prepared after approval from the
Brandeis University Human Subjects Institute Review Board and
the Brandeis University Biosafety Committee. For the hair shaft
sample, one hair, approximately 15 mm in length, with the root
removed, was cut into three sections. Each section was washed in
5% Liqui-Nox solution followed by two washes in water and
ethanol. No further separation procedures were required for hair
shaft samples prior to cell lysis.
Cell lysis prior to amplification. Cell lysis for hair shaft
was achieved using a mixture of mixture of 96 mL of Quantilyse
and 4 mL of dithiothreitol (DTT) (Sigma Gynosys
TM). Quantilyse
is a proteinase K containing lysis buffer prepared in the Wangh lab
[31]. Extracted cells were suspended in the 100 mL lysis mixture in
a 250 mL clear Applied BioSystems (ABI) reaction tube. The
250 mL tube was heated to 50uC for 2 hours then at 95uC for
15 minutes to ensure that all cellular components were entirely
broken down.
LATE-PCR protocols: reactants and reaction conditions
A l lP C Rp r e p a r a t i o nw a sc o n d u c t e di na na m p l i c o nf r e eh o o di na
clean room. All targets are kept separate from PCR reagents at all
times. PCR machines are kept in a separate room, from the
laboratory space, and as far away from the clean room as possible.
PCR amplicons and products are never handled in the laboratory
space.
HVI assay primers and probe. The amplicon produced in
amplifications of the HVI region was 549 bases in length between
bases 16458 and 15910 based on the revised Cambridge Reference
Sequence (rCRS). The excess primer (59- CACCAGTCTT-
GTAAACCGGAGATGAA - 39 target 15910–15935) had a
concentration-adjusted Tm of 62uC and was present in each
reaction at a concentration of 1 mM. The limiting primer (59 -
GCCCGGAGCGAGGAGAGTAGCACTCTTG - 39 target
16340–16458) had a concentration adjusted Tm of 68uCa n dw a s
present in a concentration of 0.05 mM.
Reactants and reaction conditions. All amplifications were
carried out in the ABI prism 7700, NTC samples were also carried
out in the BioRad IQ5, sequence detection system at a volume of
25 mL. The thermal profile was the same for all amplification
reactions and melts, as this profile was calibrated to primer, and
amplicon Tm values. The reaction mixture was initially heated to
95uC for 3 minutes, then 65 cycles of 95uC for 15 seconds, 64uC
for 10 seconds, and 72uC for 45 seconds. Accumulation of dsDNA
accumulation was monitored at 72uC using SYBRH Green
intercalating dye at a concentration of 16 (FMC Bioproducts
Rockland, ME). DNA melts assess sample purity by monitoring
the SYBRH Green fluorescence signal as the temperature
gradually increased from 35uCt o9 5 uC in 60 15 second cycles
where the temperature increased by 1 degree each cycle.
Reactants. Each 25 mL LATE-PCR reaction mixture
consisted of 106PCR buffer at a 16concentration (Invitrogen),
50 mM MgCl2 at 3 mM (Invitrogen), 10 mM dNTP’s at 250 mM
(Promega), 106 SYBRH Green (FMC Bioproducts) at 16
concentration, 10 mM limiting primer at 0.05 mMo r5 0 n M
(Operon), 100 mM excess primer at 1 mM, 10 uM 045 PrimeSafe
at 0.5 mM or 500 nM (Operon), 1.25 units of Pt Taq (Invitrogen),
de-ionized and DNA-free water (Invitrogen), and 1 mL of target
mtDNA suspended in Tris HCl buffer pH 8.3 (Sigma).
Dilute-‘N’-Go sequencing Preparation and Conditions
Preparation. The amount of ssDNA amplicon generated
during the linear phase of LATE-PCR is generally 100 to 200
times more than is needed for dideoxy-sequencing reactions [32].
Amplified samples were handled and diluted in a separate room
well away from the main laboratory space (in this case in a room
on a different floor that is vented to the outside), to a standard
concentration of approximately 25 fm/mL using Tris HCl pH 8.3.
This diluted product was then used in aliquots of 4 or 8 mL for a
total of 100 fm or 200 fm per sequencing tube.
Each sequencing sample contained 20 mL of de-ionized, DNA-
free water (Invitogen), and 4 mL of the diluted ssDNA product in
Tris HCl Buffer pH 8.0 (Sigma). In heteroplasmy experiments
where pipetting very small (1 mL) amounts of mtDNA had the
potential to reduce the accuracy of mixture ratios samples were
diluted down to 6.25 fM/mL rather than 25 fM/mL. While the
total amount of mtDNA in the prepared tube remained the same
(100 fM), the pre-sequencing mixture contained 8 mL of water,
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mixture.
Sequencing. Dideoxy-sequencing was conducted in the
Brandeis Biochemistry Core Facility on a CEQ:2000XL model
373 DNA Sequencing System (Applied Biosystems) [33].
Sequences for the validation experiments were diluted to 50 fM
[27] and sent to Genewiz, Inc. (New Jersey).
Sequence analysis. Sequence comparison was conducted
through the CLUSTAL program available online at http://www.
ebi.ac.uk/clustalw. The program aligns and scores (percent sequence
similarity) sequences facilitating base by base comparison of replicate
samples as well as comparison of sequence samples against an
established standard. The conventional sequence used as a basis of
comparison for the determination of mtDNA haplotype is the revised
Anderson sequence also known as the revised Cambridge Reference
Sequence (rCRS) which is available at http://www.mitomap.org/.
Polymorphic or heteroplasmic sites were examined using Chromas
version 2.31, a chromatogram viewing program by Technylysium
Pty. Ltd.
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